LI
CLB icon

Leap Investments’s Core Laboratories CLB Stock Holding History

Leap Investments’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$311K Buy
+15,300
New +$274K 0.2% 198

Other funds holding CLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Leap Investments's CLB Position: Q2 2020 in Review

Leap Investments opened a new position in Core Laboratories (CLB) in Q2 2020: 15,300 shares worth $311K. The stake represents 0.2% of the portfolio and ranks #198 among its holdings.

197 funds tracked by Wall St. Rank hold CLB as of Q2 2020.

  • Leap Investments held 15,300 shares of Core Laboratories worth $311K as of Q2 2020.
  • Core Laboratories was a new Leap Investments position in Q2 2020.
  • Core Laboratories made up 0.2% of Leap Investments's portfolio in Q2 2020, its #198 holding.
  • 197 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.